Scientific Reports (Mar 2024)

Proteomic analysis of serum extracellular vesicles from biliary tract infection patients to identify novel biomarkers

  • Chih-Jung Chang,
  • Yung-Ning Huang,
  • Yang-Bor Lu,
  • Yi Zhang,
  • Ping-Hua Wu,
  • Jian-Shan Huang,
  • Wei Yang,
  • Tung-Ying Chiang,
  • Hui-Shan Hsieh,
  • Wen-Hung Chung,
  • Yu-Chieh Weng

DOI
https://doi.org/10.1038/s41598-024-56036-y
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Biliary tract infection (BTI), a commonly occurring abdominal disease, despite being extensively studied for its initiation and underlying mechanisms, continues to pose a challenge in the quest for identifying specific diagnostic biomarkers. Extracellular vesicles (EVs), which emanate from diverse cell types, serve as minute biological entities that mirror unique physiological or pathological conditions. Despite their potential, there has been a relatively restricted exploration of EV-oriented methodologies for diagnosing BTI. To uncover potent protein biomarkers for BTI patients, we applied a label-free quantitative proteomic method known for its unbiased and high-throughput nature. Furthermore, 192 differentially expressed proteins surfaced within EVs isolated from individuals afflicted with BTI. Subsequent GO and KEGG analyses pinpointed Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and Crumbs homolog 3 (CRB3) as noteworthy biomarkers. Validation via data analysis of plasma-derived EV samples confirmed their specificity to BTI. Our study leveraged an unbiased proteomic tool to unveil CEACAM1 and CRB3 as promising protein biomarkers in serum EVs, presenting potential avenues for the advancement of diagnostic systems for BTI detection.